FCA Venture Partners — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
Diligent provides a centralized vendor management platform for clinical trial sponsors to discover, qualify, and oversee vendors, aiming to reduce qualification timelines and mitigate risk.
BiotechHealthtechSaaSPrinceton, US
Patricia Leuchten(Executive Officer)
Co-investorsPJC
HealthtechNashville, US
Charles Weston Crawford(Executive Officer)
BoardDevin Carty(Director)RT Wyatt(Director)Robert Ryan Chapman(Director)
Co-investorsMartin VenturesBIP Ventures
Chandler, US
Andrew Mercer(Executive Officer, Director)
Co-investorsLewis & Clark VenturesRally Ventures Management, LlcTriventuresIA Capital GroupPlug and Play VenturesSixThirty Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.